Dermatologic outcomes associated with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a large-scale target trial emulation. [PDF]
Front Endocrinol (Lausanne)Chiang YL +5 more
europepmc +1 more source
Eruptive zoophilic dermatophytosis and the expanding role of molecular diagnostics. [PDF]
AME Case RepGupta A, George A.
europepmc +1 more source
Bullous Pemphigoid Possibly Induced by Deucravacitinib in a Patient with Psoriasis. [PDF]
Clin Cosmet Investig DermatolLu X, Zhang Y, Zhang H, Tang K, Jin H.
europepmc +1 more source
Stapokibart's clinical effectiveness in treating moderate-to-severe bullous pemphigoid in the elderly. [PDF]
Front ImmunolDu N, Wang Y, Yang J, Lv X, Min W.
europepmc +1 more source
Reliability and validity of the Chinese version of the autoimmune bullous disease quality of life (ABQOL) questionnaire. [PDF]
Health Qual Life Outcomes, 2017 Yang B +6 more
europepmc +1 more source
Increased Mortality in Patients with Bullous Pemphigoid: A Nationwide Population-based Cohort Study of 5,738 Patients in Sweden. [PDF]
Acta Derm VenereolAlbadri Z +4 more
europepmc +1 more source
A Rare Type of Bullous Disorder in a Child. Can It Be Chronic Bullous Disease of Childhood? [PDF]
Clin Case RepYadav R +3 more
europepmc +1 more source
The Secretome of Bullous Pemphigoid IgG-Treated Keratinocytes Induces a Pro-Inflammatory Eosinophil Response. [PDF]
Exp DermatolMansini AP +10 more
europepmc +1 more source
A Rapidly Progressive Bullous Eruption in a Toddler. [PDF]
CureusKhalid A, Ghouri S, Proano JS.
europepmc +1 more source
Bullous Rheumatoid Neutrophilic Dermatosis-A Systematic Review of 28 Cases. [PDF]
J Clin MedMazur E +4 more
europepmc +1 more source